4-chlorophenylalanine methyl ester has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aydın, TH; Can, ÖD; Demir Özkay, Ü; Turan, N | 1 |
Ohkubo, Y; Takeshita, N; Yamaguchi, I | 1 |
2 other study(ies) available for 4-chlorophenylalanine methyl ester and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
Topics: Acetamides; Animals; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fenclonine; Hyperalgesia; Hyperglycemia; Methyltyrosines; Neuralgia; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Streptozocin | 2016 |
Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
Topics: Animals; Central Nervous System; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dopamine Antagonists; Female; Fenclonine; Indoles; Injections, Spinal; Ketanserin; Male; Mice; Nociceptors; Pain; Pain Measurement; Pindolol; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Synaptic Transmission; Tiapamil Hydrochloride; Tropisetron | 1995 |